Charles M. Darling, IV

President & CEO


Mr. Darling has been involved in project development and investment for over 30 years.  Previously, he was President, General Counsel and Director of a publicly traded energy company.  Mr. Darling practiced law for 25 years with Baker Botts, LLP.  Mr. Darling has been working on developing projects nationally and internationally throughout most of his career.  He is currently serving on the Board of Directors of a New York Stock Exchange traded company.

Catherine M. Fonfara

Sr. Vice President - Finance


Ms. Fonfara worked in the legal area for 30 years, the last 12 of which were with Baker Botts, LLP.  Prior to that she worked for a Prince of the Kingdom of Saudi Arabia, assisting him in his duties with the United Nations in Third-World countries.  She became involved in the energy industry in the late 1980's and, thereafter, with project development with DQ Holdings.

Charles M. Darling, V

Vice President - International Operations


Mr. Darling has been involved in various startup companies, project developments and investments for over 15 years.  Mr. Darling is the President and Chief Operating Office of DQ Holdings' affiliate, DQ China Holdings, LLC.  He spends his time between Beijing and San Francisco where he is handling the international operations of DermaClip.

Christopher B Darling

Vice President - Operations


Mr. Darling has worked in finance and business development roles for over 5 years.  Most recently, he was an Assistant Vice President in BNP Paribas Fortis' Brussels and New Yrok Offices and with Deloitte Consulting in New York.

What's New

Houston, TX, January 13, 2020, DermaClip, LLC announced today the addition of Kirk Sanders to the key position of Vice President of Sales.  Mr. Sanders is an established sales leader in the medical device market place, with over 30 years in the wound closure field.  Charles Darling, CEO of DermaClip stated, "We are delighted to have Kirk join us to lead our sales efforts in the hospital marketplace.  He is uniquely positioned to help us fully develope the market potential of the DermaClip device.  He meaningfully strengthens our management team."

Print | Sitemap
© DQ Holdings, LLC